Announcements Trials
Browse Landscape

Phase

Phase 2 44Phase 1 32Phase 1/2 21Phase 3 9Phase NA 3Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 7Recruiting 5Active not recruiting 3Withdrawn 2Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms 1Glioma 1

Interventions

Magnetic Resonance Spectroscopy 7Cyclophosphamide 6pembrolizumab 5Radiosurgery 5Nivolumab 4Fluorouracil 4Carboplatin 4Blood Specimen Collection 4Biopsy 4X-Rays 3Vincristine 3Surveys and Questionnaires 3Proflavine 3Positron-Emission Tomography 3Metformin 3Cisplatin 3Bevacizumab 3fludarabine phosphate 2durvalumab 2atezolizumab 2Varenicline 2Topotecan 2Taxes 2Specimen Handling 2Rituximab 2Radiotherapy 2Positron Emission Tomography Computed Tomography 2Oxaliplatin 2Leucovorin 2Letrozole 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Terminated × Temozolomide × Clear all
NCT02507232 2020-07-28

Study of NovoTTF-200A Alone and With Temozolomide in Patients With Low-Grade Gliomas

Saint John's Cancer Institute

Phase EARLY_PHASE1 Terminated
2 enrolled
CNS

Glioma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡